立体定向脑活检术后临终关怀入组的预测:回顾性研究与风险评分开发
该回顾性研究纳入2000至2022年在一家三级学术中心接受立体定向脑活检的616例患者,主要结局为术后1个月内临终关怀入组。1个月临终关怀入组率为12.7%,独立预测因素包括年龄≥60岁、基底节活检、精神状态缺陷、KPS≤50、ICU住院时间延长及4级胶质瘤;综合风险评分训练集乐观校正AUC为0.81(测试集0.85),术前-only评分训练集AUC为0.78(测试集0.82)。
要点
- 术后1个月临终关怀入组率为12.7%,需术前识别高风险患者。
- 独立预测因素包括年龄≥60岁、基底节活检、KPS≤50、4级胶质瘤等。
- 综合风险评分测试集高风险患者1个月临终关怀入组概率为88.9%。
核心结论
- 本研究提出并验证了预测立体定向脑活检术后早期临终关怀入组的风险模型。
- 将风险工具纳入术前评估可能支持知情咨询、减少不必要操作或治疗、促进共享决策并减轻经济负担。
研究设计与样本
- 回顾性分析616例2000至2022年在三级学术中心接受立体定向脑活检的患者,并补充截至2025年的费用数据。
- 主要结局为术后1个月内临终关怀入组,采用多变量Firth逻辑回归识别预测因素并开发及验证概率性术前和术后风险评分。
主要发现
- 1个月临终关怀入组率为12.7%。
- 独立预测因素包括年龄≥60岁、基底节活检、精神状态缺陷、KPS≤50、ICU住院时间延长及4级胶质瘤。
- 综合风险评分训练集乐观校正AUC为0.81(测试集0.85),测试集高风险患者1个月临终关怀入组概率为88.9%。
- 术前-only风险评分训练集AUC为0.78(测试集0.82)。
- 临终关怀患者院内护理费用显著更高(54,499美元 vs 35,967美元)。
关键数值与推荐
- 综合风险评分训练集乐观校正AUC为0.81,测试集为0.85。
- 术前-only风险评分训练集AUC为0.78,测试集为0.82。
- 测试集高风险患者1个月临终关怀入组概率为88.9%。
临床怎么用
- 术前使用风险评分识别可能早期入组临终关怀的患者,辅助知情咨询与共享决策。
- 对高风险患者审慎评估立体定向脑活检的必要性,以减少不必要操作或治疗。
局限性
- 本研究为单中心回顾性分析,结论的外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Stereotactic brain biopsy (SBB) is a key diagnostic tool in neuro-oncology. Due to the poor prognosis for many tumors, a significant subset of patients transition to hospice care shortly after the procedure. Current tools inadequately predict which patients are less likely to benefit from SBB. This study aimed to define preoperative factors that limit enrollment in adjuvant treatment in SBB candidates by characterizing patients who enrolled in hospice soon after the procedure. Understanding the safety profile and diagnostic utility of SBB in the context of hospice enrollment is essential for making informed decisions. METHODS: A retrospective analysis was conducted on 616 patients who underwent SBB between 2000 and 2022 at a tertiary academic center with additional cost-of-care data up to 2025. Clinical, surgical, and pathological data were analyzed. The primary outcome was hospice enrollment within 1 month postoperatively. Multivariable Firth logistic regression identified key predictors, which were used to develop and validate probabilistic pre- and postoperative risk scores. A secondary cost analysis compared financial burdens between hospice and nonhospice patients. RESULTS: One-month hospice enrollment occurred in 12.7% of patients. Independent predictors of hospice enrollment included age ≥ 60 years, basal ganglia biopsy, mental status deficits, Karnofsky Performance Status (KPS) score ≤ 50, prolonged intensive care unit stay, and grade 4 glioma. The comprehensive risk score achieved an optimism-corrected area under the receiver operating characteristic curve (AUC) of 0.81 at train time (0.85 test), with high-risk test-set patients having an 88.9% probability of 1-month hospice enrollment. The preoperative-only risk score attained a train time AUC of 0.78 (0.82 test). Patients progressing to hospice incurred significantly higher in-hospital care costs ($54,499 vs $35,967). Preoperative functional impairment (as measured by the KPS score) was also associated with higher 1-year hospice enrollment and 1-year mortality rates. CONCLUSIONS: This study presents a validated risk model predicting early hospice enrollment after SBB. Incorporating this tool into preoperative assessment may support clinicians in informed counseling, reduce unnecessary procedures or treatment, enhance shared decision-making, and mitigate financial burden, ultimately promoting patient-centered neuro-oncological care.
引用
- Tripathy A, Harake ES, Ahmad A, et al. Predicting postoperative hospice enrollment following stereotactic brain biopsy: a retrospective study and risk score development. J Neurosurg. 2026. PMID: 42537242. doi:10.3171/2026.2.JNS251994
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。